Alaina Jaster, PhD

New paper alert 🚨and my first co-author under @wsuthinklab 🤩 Endocannabinoid dysregulation & PTSD in urban adolescents link.springer.com/article/10.100…

Thank you for asking. You seem serious. Yes, patient access is important. This isn't about access. Mindbloom is introducing people to minimally supervised injectable ketamine. This is a public health experiment. A few comments:

SSDP's Drug Education Committee is hard at work revamping our Just Say Know curriculum to provide comprehensive, unbiased, and evidence-based drug education for students and youth across the country. We need your help to make it happen here: buff.ly/4iEWEz3

What are your favorite or least favorite psychedelic moments this year? Most standout events/papers/talks? Let us know!!

how it feels sending work emails in december

Like they do not have abuse potential, they don’t even act through the same mechanisms as other drugs that have higher abuse potential, they’re pharmacokinetics do not share hallmarks with commonly used drugs ITS A FEATURE NOT A BUG!!!

I would love to know who decided that bc psychedelics don’t produce self-admin that assay isn’t valid to measure their abuse liability When IN FACT the “limited” or “sporadic” or “unreliable” self-admin of psychs is consistent with the use patterns of humans smh

How do we live better knowing we will someday die? 💀 Alex Sielaff, PhD, dives into existential psychology and explores how psychs, breathwork, and other out there experiences might (or might not) help us live more meaningful lives. 🌌 open.spotify.com/episode/2W0ZEf…

My latest, via @Filtermag_org! Honored to be able to expand my coverage back to my home state — I grew up less than an hour from Louisa County and hope to interview Dawn Morris in person before she’s sentenced in February.

When writing a paper or doing an analysis would you say it’s important to include data published in the last 5 years leading up to your publication?

@JackGorsline 😹😹 Makes me hungry

Animal researchers - Is drug discrimination still considered the golden standard for assessing abuse liability in 2024?

@HDourron Wish you could tell this to the DEA! They still believe it

whoever thought psychs, aka drugs with a relatively consistent mechanisms, would model any neurological aspect of something as heterogeneous as first-episode psychosis was really cute...

"it will be so easy to model psychosis" lol ... pubmed.ncbi.nlm.nih.gov/39228736/

The never-ending millennial struggle to refrain from ending a sentence in an email with “lol” is EXHAUSTING.

@JackGorsline I LOVE Vegas lmao

First time visiting Las Vegas this week for MJBiz Con and while (in my opinion) Las Vegas is both highly overrated and wildly overpriced, I am so lucky to have been able to scrounge up the spare change to make the trip out here.

New publication from CPCR Faculty Albert Garcia-Romeu, Sandeep Nayak (@sdpnayak), Nathan Sepeda (@n_sepeda), and colleagues! sciencedirect.com/science/articl…

Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activati… pubmed.ncbi.nlm.nih.gov/39541872/

Our final episode in the #psychedelic circuitry series!! And maybe the year?? This episode dives into threat, amygdala, PVN + how psychedelics alter these responses in male and females animal models! Featuring the great @devin_effinger! psychedelicbrainscience.com/podcast/episod…

@harrington5150 Thank you Devon!

I want to take a moment to thank and acknowledge @JasterAlaina for her incredible bravery and conviction on day two of the DEA hearing to place DOI and DOC in schedule 1. I am incredibly impressed with her and would love to sit down and speak with her about this experience.

Best of luck to all submitting grad school apps this cycle! It’s been a privilege to support some amazing folks ☀️ PLEASE remember that your worth is NOT dependent on the outcome — it’s truly so subjective & there will ALWAYS be more chances. You deserve rest & celebration! 🙌🏾🫶🏾

"thanks so much for the feedback"